Comera life sciences presents sqore™ platform technology data at podd: partnerships in drug delivery conference

Woburn, mass., oct. 16, 2023 (globe newswire) -- comera life sciences holdings, inc. (nasdaq: cmra), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today will present research demonstrating comera's sqore™ platform capabilities in the development of subcutaneous monoclonal antibody formulations at the podd: partnerships in drug delivery conference in boston, mass.
CMRA Ratings Summary
CMRA Quant Ranking